Thomas J. Huizinga
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA Trials.
Journal: Joint bone spine
Published: February 24, 2026
Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials.
Journal: Joint bone spine
Published: February 24, 2026
Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: December 22, 2025
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis.
Journal: Annals of the rheumatic diseases
Published: July 24, 2025
Baseline Interleukin-10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease-Modifying Antirheumatic Drug Naive and Anti-Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 30, 2025
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study.
Journal: The Journal of rheumatology
Published: December 18, 2024
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024.
Journal: Annals of the rheumatic diseases
Published: October 11, 2024
Infliximab biosimilar GP1111: a review of 5 years' post-approval experience.
Journal: Expert opinion on biological therapy
Published: July 08, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Journal: Lancet (London, England)
Published: August 21, 2023
A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners.
Journal: Glycobiology
Published: April 28, 2023
Author Correction: Glycobiology of rheumatic diseases.
Journal: Nature reviews. Rheumatology
Published: February 23, 2023
Last Updated: 09/26/2026